Steward Partners Investment Advisory’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $202K | Sell |
900
-233
| -21% | -$58.1K | ﹤0.01% | 2014 |
|
|
2025
Q4 | $273K | Sell |
1,133
-64
| -5% | -$16.4K | ﹤0.01% | 1763 |
|
|
2025
Q3 | $328K | Buy |
1,197
+557
| +87% | +$152K | ﹤0.01% | 1609 |
|
|
2025
Q2 | $165K | Sell |
640
-4
| -0.6% | -$954 | ﹤0.01% | 1846 |
|
|
2025
Q1 | $144K | Buy |
644
+43
| +7% | +$10K | ﹤0.01% | 1809 |
|
|
2024
Q4 | $137K | Sell |
601
-3
| -0.5% | -$722 | ﹤0.01% | 1812 |
|
|
2024
Q3 | $148K | Sell |
604
-16
| -3% | -$3.58K | ﹤0.01% | 1677 |
|
|
2024
Q2 | $119K | Sell |
620
-50
| -7% | -$10.1K | ﹤0.01% | 1699 |
|
|
2024
Q1 | $133K | Sell |
670
-519
| -44% | -$95.1K | ﹤0.01% | 1619 |
|
|
2023
Q4 | $205K | Buy |
1,189
+225
| +23% | +$34.6K | ﹤0.01% | 1369 |
|
|
2023
Q3 | $142K | Sell |
964
-4,333
| -82% | -$783K | ﹤0.01% | 1417 |
|
|
2023
Q2 | $1.16M | Buy |
5,297
+667
| +14% | +$149K | 0.02% | 646 |
|
|
2023
Q1 | $1.01M | Buy |
4,630
+202
| +5% | +$43.8K | 0.02% | 692 |
|
|
2022
Q4 | $922K | Buy |
4,428
+4,107
| +1,279% | +$902K | 0.02% | 693 |
|
|
2022
Q3 | $70K | Sell |
321
-3
| -0.9% | -$683 | ﹤0.01% | 1634 |
|
|
2022
Q2 | $68K | Sell |
324
-32
| -9% | -$6.81K | ﹤0.01% | 1654 |
|
|
2022
Q1 | $86K | Sell |
356
-353
| -50% | -$85.4K | ﹤0.01% | 1668 |
|
|
2021
Q4 | $185K | Hold |
709
| – | – | ﹤0.01% | 1346 |
|
|
2021
Q3 | $187K | Sell |
709
-18
| -2% | -$4.92K | ﹤0.01% | 1300 |
|
|
2021
Q2 | $179K | Sell |
727
-96
| -12% | -$20.2K | ﹤0.01% | 1621 |
|
|
2021
Q1 | $160K | Buy |
823
+170
| +26% | +$34.1K | ﹤0.01% | 1397 |
|
|
2020
Q4 | $139K | Buy |
653
+26
| +4% | +$5.18K | ﹤0.01% | 1225 |
|
|
2020
Q3 | $107K | Sell |
627
-3
| -0.5% | -$554 | ﹤0.01% | 1196 |
|
|
2020
Q2 | $121K | Buy |
630
+297
| +89% | +$48.6K | ﹤0.01% | 1068 |
|
|
2020
Q1 | $49K | Hold |
333
| – | – | ﹤0.01% | 1272 |
|
|
2019
Q4 | $51K | Hold |
333
| – | – | ﹤0.01% | 1382 |
|
|
2019
Q3 | $44K | Hold |
333
| – | – | ﹤0.01% | 1412 |
|
|
2019
Q2 | $40K | Buy |
+333
| New | +$36.9K | ﹤0.01% | 1424 |
|
|
2018
Q4 | – | Sell |
-333
| Closed | -$38K | – | 1859 |
|
|
2018
Q3 | $38K | Sell |
333
-34
| -9% | -$3.72K | ﹤0.01% | 1306 |
|
|
2018
Q2 | $38K | Hold |
367
| – | – | ﹤0.01% | 1207 |
|
|
2018
Q1 | $36K | Buy |
367
+89
| +32% | +$8.41K | ﹤0.01% | 1117 |
|
|
2017
Q4 | $23K | Buy |
278
+166
| +148% | +$13.7K | ﹤0.01% | 1071 |
|
|
2017
Q3 | $8K | Buy |
112
+34
| +44% | +$2.6K | ﹤0.01% | 1177 |
|
|
2017
Q2 | $6K | Hold |
78
| – | – | ﹤0.01% | 1181 |
|
|
2017
Q1 | $5K | Buy |
78
+64
| +457% | +$4.42K | ﹤0.01% | 1127 |
|
|
2016
Q4 | $0 | Buy |
+14
| New | +$857 | ﹤0.01% | 888 |
|
Other funds holding RMD
VCM
VPM
DAM
Steward Partners Investment Advisory's RMD Position: Q1 2026 in Review
Steward Partners Investment Advisory reduced its ResMed (RMD) stake by 21% in Q1 2026, selling an estimated $58.1K and leaving 900 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #2014.
Steward Partners Investment Advisory first reported a position in RMD in Q4 2016 and has held it in 36 quarters since. The position peaked at $1.16M in Q2 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Steward Partners Investment Advisory held 900 shares of ResMed worth $202K as of Q1 2026.
- Steward Partners Investment Advisory sold 233 ResMed shares in Q1 2026, an estimated $58.1K.
- ResMed made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #2014 holding.
- Steward Partners Investment Advisory first reported a position in ResMed in Q4 2016 and has held it in 36 quarters since.
- Steward Partners Investment Advisory's ResMed position peaked at $1.16M in Q2 2023.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.